Cognizant collaborates with alnylam as technology services partner to scale it operations

Utilizing cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance alnylam's automation and reduce operational efforts teaneck, n.j. , oct. 29, 2024 /prnewswire/ -- cognizant (nasdaq: ctsh) announced today a new agreement with alnylam pharmaceuticals, inc., a leading biopharmaceutical company and the pioneer in rna interference (rnai) therapeutics.
CTSH Ratings Summary
CTSH Quant Ranking